Gilead and Nucleai probe why target-positive tumors can still resist ADCs
recent articles
Upcoming Paige Webinar Going Digital in Pathology Key Factors to Consider Before the Transition Tuesday, March 15, 2022 | 13:00 GMT/ 8:00 AM EST Register Now Tuesday, March 15,...
Mission Bio: Pioneering cancer pathologist Jorge Reis-Filho’s lab at Memorial Sloan Kettering Cancer Center to develop best practices integrating Tapestri single-cell multi-omics capabilities SOUTH SAN FRANCISCO, March 1, 2022 — Mission...
Sectra and NPIC Collaboration Expansion to Help Accelerate Digital Pathology Across the UK Linköping, Sweden – March 3, 2022 –The National Pathology Imaging Co-operative (NPIC) is expanding the use of international medical...
Visiopharm, a world leader in AI-driven precision pathology software, today announced that its existing portfolio of diagnostic apps have all been certified under the new In Vitro Diagnostic Regulation (IVDR). The major difference between...
Partnership to provide access to Flagship’s AI-aided software for quantifying PD-L1 IHC stains across various tissue types NEW YORK & BROOMFIELD, Colo.--(BUSINESS WIRE)--Paige,the global leader in AI-based diagnostic software in...
Mountain View, California, February 28, 2022 – Crosscope Inc. a leading provider of AI-enabled digital pathology software and Mindpeak Gmbh, known for building sophisticated AI tools for clinical diagnosis, today announced their...
